TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
Conditions:   Crohn Disease;   Infliximab;   Perianal Fistula Due to Crohn's Disease;   Therapeutic Drug Monitoring;   Magnetic Resonance Novel Index for Fistula Imaging in Crohn's Disease Score Interventions:   Drug: TDM-based infliximab intravenous therapy;   Drug: Standard infliximab intravenous therapy Sponsor:   Asan Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
Conditions: Crohn Disease; Infliximab; Perianal Fistula Due to Crohn ' s Disease; Therapeutic Drug Monitoring; Magnetic Resonance Novel Index for Fistula Imaging in Crohn ' s Disease Score Interventions: Drug: TDM-based infliximab intravenous therapy; Drug: Standard infliximab intravenous therapy Sponsors: Asan Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Condition:   Crohn's Disease Interventions:   Drug: Vedolizumab;   Drug: Adalimumab;   Drug: Ustekinumab Sponsor:   Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials